Laboratório de Química Farmacêutica Medicinal, Programa de Pós-Graduação em Farmácia, CCS, Universidade Federal de Santa Catarina. Campus Universitário, 88040900, Florianópolis, Brasil; Université de Lyon, INSA Lyon, Université Lyon 1, CNRS, CPE Lyon, UMR 5246, ICBMS. 1 rue Victor Grignard, 69621, Villeurbanne Cedex, France.
Laboratório de Protozoologia, CCB, Universidade Federal de Santa Catarina. Campus Universitário, 88040900, Florianópolis, Brasil.
Bioorg Chem. 2022 Feb;119:105492. doi: 10.1016/j.bioorg.2021.105492. Epub 2021 Nov 15.
Chemical scaffolds of natural products have historically been sources of inspiration for the development of novel molecules of biological relevance, including hit and lead compounds. To identify new compounds active against Trypanosoma cruzi, we designed and synthesized 46 synthetic derivatives based on the structure of two classes of natural products: tetrahydrofuran lignans (Series 1) and oxazole alkaloids (Series 2). Compounds were screened in vitro using a cellular model of T. cruzi infection. In the first series of compounds, 11 derivatives of hit compound 5 (EC = 1.1 µM) were found to be active; the most potent (7, 8, and 13) had EC values of 5.1-34.2 µM. In the second series, 17 analogs were found active at 50 µM; the most potent compounds (47, 49, 59, and 63) showed EC values of 24.2-49.1 µM. Active compounds were assessed for selectivity, hemocompatibility, synergistic potential, effects on mitochondrial membrane potential, and inhibitory effect on trypanothione reductase. All active compounds showed low toxicity against uninfected THP-1 cells and human erythrocytes. The potency of compounds 5 and 8 increased steadily in combination with benznidazole, indicating a synergistic effect. Furthermore, compounds 8, 47, 49, 59, and 63 inhibited parasitic mitochondria in a dose-dependent manner. Although increased reactive oxygen species levels might lead to mitochondrial effects, the results indicate that the mechanism of action of the compounds is not dependent on trypanothione reductase inhibition. In silico calculation of chemical descriptors and principal component analysis showed that the active compounds share common chemical features with other trypanocidal molecules and are predicted to have a good ADMET profile. Overall, the results suggest that the compounds are important candidates to be further studied for their potential against T. cruzi.
天然产物的化学支架历来是开发具有生物相关性的新型分子(包括命中化合物和先导化合物)的灵感来源。为了鉴定对抗克氏锥虫有效的新化合物,我们设计并合成了 46 种基于两类天然产物结构的合成衍生物:四氢呋喃木脂素(系列 1)和恶唑生物碱(系列 2)。使用克氏锥虫感染的细胞模型在体外筛选化合物。在第一系列化合物中,发现 11 种命中化合物 5 的衍生物具有活性(EC=1.1µM);最有效的(7、8 和 13)的 EC 值为 5.1-34.2µM。在第二系列中,发现 17 种类似物在 50µM 时具有活性;最有效的化合物(47、49、59 和 63)的 EC 值为 24.2-49.1µM。对具有活性的化合物进行了选择性、血液相容性、协同潜力、对线粒体膜电位的影响以及对 trypanothione 还原酶的抑制作用评估。所有具有活性的化合物对未感染的 THP-1 细胞和人红细胞的毒性都较低。化合物 5 和 8 的效力与苯并硝唑联合使用时稳步增加,表明存在协同作用。此外,化合物 8、47、49、59 和 63 以剂量依赖的方式抑制寄生线粒体。尽管活性氧水平升高可能导致线粒体效应,但结果表明化合物的作用机制不依赖于 trypanothione 还原酶抑制。化学描述符的计算和主成分分析表明,活性化合物与其他杀锥虫分子具有共同的化学特征,预计具有良好的 ADMET 特性。总体而言,结果表明这些化合物是对抗克氏锥虫的潜在重要候选物,值得进一步研究。